Fulvestrant Injection (Fulvenat 250mg Injection)

Description

Introduction Of Fulvenat 250mg Injection:

Fulvenat 250mg Injection contains Fulvestrant, an estrogen receptor antagonist (estrogen blocker) used in the treatment of hormone receptor-positive breast cancer in postmenopausal women.

Fulvenat 250mg Injection is administered only by a trained healthcare professional as an intramuscular injection, usually given slowly into the buttock. Your doctor will decide the dose and schedule based on your condition and treatment plan, and it may be used alone or together with other breast cancer medicines. It should never be self-administered.

Injection site pain, nausea, and tiredness are among the most common effects of this medicine. Your doctor may advise regular monitoring of your liver function during treatment. Inform your doctor if you notice yellowing of the skin or eyes, unusual bleeding, or severe pain, swelling, or redness at the injection site.

Uses Of Fulvenat 250mg Injection:

• Hormone Receptor-Positive Breast Cancer in postmenopausal women
• Locally advanced or metastatic breast cancer

Benefits Of Fulvenat 250mg Injection:

1. Hormone Receptor-Positive Breast Cancer

Many breast cancers rely on the hormone estrogen to grow. Fulvenat 250mg Injection works by blocking estrogen receptors on cancer cells, which helps slow the growth of tumors that depend on estrogen.

2. Locally Advanced or Metastatic Breast Cancer

In advanced breast cancer, including cases that have progressed after earlier hormone therapy, Fulvenat 250mg Injection helps control disease progression and supports the overall treatment plan.

Side effects of Fulvenat 250mg Injection:

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Common side effects of Fulvestrant:

• Pain at injection site
• Nausea
• Fatigue
• Headache
• Bone pain
• Joint and muscle pain
• Hot flashes
• Weakness

Mechanism Of Action Of Fulvenat 250mg Injection:

Fulvenat Injection contains Fulvestrant, an estrogen receptor antagonist. It binds to estrogen receptors on breast cancer cells, blocks the effect of estrogen, and also reduces the number of these receptors. This stops estrogen from driving the growth of cancer cells, helping slow the progression of the disease.

Contact Us